Medicinal species as MTDLs: Turnera diffusa Willd. Ex Schult inhibits CNS enzymes and delays glutamate excitotoxicity in SH-SY5Y cells via oxidative damage

Food and Chemical Toxicology

Volumn 106, Issue , 2017, Pages 466-476

  Bernardo, João ^a   Ferreres, Federico ^b   Gil Izquierdo, Ángel ^b   Valentão, Patrícia ^a   Andrade, Paula B ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

CNS enzymes; Flavonoids; Glutamate excitotoxicity; Medicinal species; Neuroprotection; Turnera diffusa

Indexed keywords

ACACETIN; ACETYLCHOLINESTERASE; ACORUS CALAMUS EXTRACT; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; ANTINEOPLASTIC AGENT; APIGENIN; APIGETRIN; CEREUS GRANDIFLORUS EXTRACT; CHOLINESTERASE; FLAVONOID; GLUTAMIC ACID; HYSSOPUS OFFICINALIS EXTRACT; ISOORIENTIN; ISOQUERCITRIN; LUTEOLIN; LUTEOLIN 7 GLUCOSIDE; MYRICITRIN; ORIENTIN; PHENOL DERIVATIVE; PLANT EXTRACT; QUERCETIN; SILYBUM MARIANUM EXTRACT; TURNERA DIFFUSA EXTRACT; UNCLASSIFIED DRUG; VELUTIN; ANTIOXIDANT; REACTIVE OXYGEN METABOLITE;

ACORUS CALAMUS; ARTICLE; CELL DEATH; CELL PROTECTION; CELL VIABILITY; CEREUS GRANDIFLORUS; CHEMICAL COMPOSITION; CONTROLLED STUDY; EC50; ENZYME INHIBITION; EXCITOTOXICITY; FLOWER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYSSOPUS OFFICINALIS; IC50; IN VITRO STUDY; MEDICINAL PLANT; NEUROBLASTOMA CELL LINE; NONHUMAN; OXIDATIVE STRESS; PLANT LEAF; RHIZOME; SILYBUM MARIANUM; TURNERA DIFFUSA; CELL LINE; CENTRAL NERVOUS SYSTEM DISEASES; CHEMISTRY; DRUG EFFECTS; MASS SPECTROMETRY; METABOLISM; TURNERA;

ANTIOXIDANTS; CELL LINE; CENTRAL NERVOUS SYSTEM DISEASES; GLUTAMIC ACID; HUMANS; MASS SPECTROMETRY; OXIDATIVE STRESS; PHENOLS; PLANT EXTRACTS; PLANTS, MEDICINAL; REACTIVE OXYGEN SPECIES; TURNERA;

EID: 85020789715     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2017.06.014     Document Type: Article

References (51)

1. Atlante, A., Calissano, P., Bobba, A., Giannattasio, S., Marra, E., Passarella, S., Glutamate neurotoxicity, oxidative stress and mitochondria. FEBS Lett. 497 (2001), 1–5, 10.1016/S0014-5793(01)02437-1.
2. Bautista-Aguilera, O.M., Esteban, G., Bolea, I., Nikolic, K., Agbaba, D., Moraleda, I., Iriepa, I., Samadi, A., Soriano, E., Unzeta, M., Marco-Contelles, J., Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease. Eur. J. Med. Chem. 75 (2014), 82–95, 10.1016/j.ejmech.2013.12.028.
3. Bernardo, J., Valentão, P., Grosso, C., Andrade, P., Flavonoids in neurodegeneration: limitations and strategies to cross CNS barriers. Curr. Med. Chem. 23 (2016), 4151–4174, 10.2174/0929867323666160809094934.
4. Bhullar, K.S., Rupasinghe, H.P.V., Polyphenols: multipotent therapeutic agents in neurodegenerative diseases. Oxid. Med. Cell. Longev., 2013, 2013, 891748, 10.1155/2013/891748.
5. Bohnen, N.I., Albin, R.L., The cholinergic system and Parkinson disease. Behav. Brain Res. 221 (2011), 564–573, 10.1016/j.bbr.2009.12.048.
6. Cassano, T., Pace, L., Bedse, G., Michele Lavecchia, A., De Marco, F., Gaetani, S., Serviddio, G., Glutamate and mitochondria: two prominent players in the oxidative stress-induced neurodegeneration. Curr. Alzheimer Res. 13 (2016), 185–197, 10.2174/1567205013666151218132725.
7. Chatonnet, A., Lockridgetl, O., Comparison of butyrylcholinesterase and acetylcholinesterase. Biochem. J. 260 (1989), 625–634, 10.1111/j.1600-0730.1981.tb00784.x.
8. Chen, X., Decker, M., Multi-target compounds acting in the central nervous system designed from natural products. Curr. Med. Chem. 20 (2013), 1673–1685, 10.2174/0929867311320130007.
9. Choi, J.S., Islam, M.N., Ali, M.Y., Kim, Y.M., Park, H.J., Sohn, H.S., Jung, H.A., The effects of C-glycosylation of luteolin on its antioxidant, anti-Alzheimer's disease, anti-diabetic, and anti-inflammatory activities. Arch. Pharm. Res. 37 (2014), 1354–1363, 10.1007/s12272-014-0351-3.
10. Dittmann, K., Riese, U., Hamburger, M., HPLC-based bioactivity profiling of plant extracts: a kinetic assay for the identification of monoamine oxidase-A inhibitors using human recombinant monoamine oxidase-A. Phytochemistry 65 (2004), 2885–2891, 10.1016/j.phytochem.2004.07.024.
11. Ebrahimi, A., Schluesener, H., Natural polyphenols against neurodegenerative disorders: potentials and pitfalls. Ageing Res. Rev. 11 (2012), 329–345, 10.1016/j.arr.2012.01.006.
12. Erdogan Orhan, I., Potential of natural products of herbal origin as monoamine oxidase inhibitors. Curr. Pharm. Des. 22 (2016), 268–276, 10.2174/1381612822666151112150612.
13. Fan, P., Hay, A.-E., Marston, A., Hostettmann, K., Acetylcholinesterase-inhibitory activity of linarin from Buddleja davidii, structure-activity relationships of related flavonoids, and chemical investigation of Buddleja nitida. Pharm. Biol. 46 (2008), 596–601, 10.1080/13880200802179592.
14. Ferreres, F., Andrade, P.B., Valentão, P., Gil-Izquierdo, A., Further knowledge on barley (Hordeum vulgare L.) leaves O-glycosyl-C-glycosyl flavones by liquid chromatography-UV diode-array detection-electrospray ionisation mass spectrometry. J. Chromatogr. A 1182 (2008), 56–64, 10.1016/j.chroma.2007.12.070.
15. Ferreres, F., Bernardo, J., Andrade, P.B., Sousa, C., Gil-Izquierdo, A., Valentão, P., Pennyroyal and gastrointestinal cells: multi-target protection of phenolic compounds against t-BHP-induced toxicity. RSC Adv. 5 (2015), 41576–41584, 10.1039/C5RA02710A.
16. n with respect to authentication and enzyme inhibition potential. Ind. Crops Prod. 77 (2015), 391–401, 10.1016/j.indcrop.2015.09.006.
17. n analysis of phenolic compounds for quality control of Grindelia robusta Nutt. and bioactivities. J. Pharm. Biomed. Anal. 94 (2014), 163–172, 10.1016/j.jpba.2014.01.046.
18. Ferreres, F., Silva, B.M., Andrade, P.B., Seabra, R.M., Ferreira, M.A., Approach to the study of C-glycosyl flavones by ion trap HPLC-PAD-ESI/MS/MS: application to seeds of quince (Cydonia oblonga). Phytochem. Anal. 14 (2003), 352–359, 10.1002/pca.727.
19. Ferreres, F., Sousa, C., Valentão, P., Andrade, P.B., Seabra, R.M., Gil-Izquierdo, Á., New C-deoxyhexosyl flavones and antioxidant properties of Passiflora edulis leaf extract. J. Agric. Food Chem. 55 (2007), 10187–10193, 10.1021/jf072119y.
20. Gao, M., Zhang, W. cui, Liu, Q. shan, Hu, J. juan, Liu, G. tao, Du, G. hua, Pinocembrin prevents glutamate-induced apoptosis in SH-SY5Y neuronal cells via decrease of bax/bcl-2 ratio. Eur. J. Pharmacol. 591 (2008), 73–79, 10.1016/j.ejphar.2008.06.071.
21. Garcia, C.J., García-Villalba, R., Garrido, Y., Gil, M.I., Tomás-Barberán, F.A., Untargeted metabolomics approach using UPLC-ESI-QTOF-MS to explore the metabolome of fresh-cut iceberg lettuce. Metabolomics, 12, 2016, 10.1007/s11306-016-1082-x.
22. Gomes, N.G.M., Campos, M.G., Órfão, J.M.C., Ribeiro, C. a F., Plants with neurobiological activity as potential targets for drug discovery. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 33 (2009), 1372–1389, 10.1016/j.pnpbp.2009.07.033.
23. Grosso, C., Valentão, P., Andrade, C., Andrade, P.B., HPLC-DAD analysis and in vitro enzyme inhibition: an integrated approach to predict herbal binary mixture behaviour employing median effect equation. Microchem. J. 119 (2015), 176–182, 10.1016/j.microc.2014.12.006.
24. Grosso, C., Valentão, P., Ferreres, F., Andrade, P.B., The use of flavonoids in central nervous system disorders. Curr. Med. Chem. 20 (2013), 4694–4719, 10.2174/09298673113209990155.
25. Houghton, P.J., Ren, Y., Howes, M.-J., Acetylcholinesterase inhibitors from plants and fungi. Nat. Prod. Rep. 23 (2006), 181–199, 10.1039/b508966m.
26. Jin, X., Liu, Q., Jia, L., Li, M., Wang, X., Pinocembrin attenuates 6-OHDA-induced neuronal cell death through Nrf2/ARE pathway in SH-SY5Y cells. Cell. Mol. Neurobiol. 35 (2015), 323–333, 10.1007/s10571-014-0128-8.
27. Kang, S.S., Lee, J.Y., Choi, Y.K., Kim, G.S., Han, B.H., Neuroprotective effects of flavones on hydrogen peroxide-induced apoptosis in SH-SY5Y neuroblostoma cells. Bioorg. Med. Chem. Lett. 14 (2004), 2261–2264, 10.1016/j.bmcl.2004.02.003.
28. Kritis, A.A., Stamoula, E.G., Paniskaki, K.A., Vavilis, T.D., Researching glutamate -induced cytotoxicity in different cell lines: a comparative/collective analysis/study. Front. Cell. Neurosci., 9, 2015, 91, 10.3389/fncel.2015.00091.
29. Kumar, S., Sharma, A., Apigenin: the anxiolytic constituent of Turnera aphrodisiaca. Pharm. Biol. 44 (2006), 84–90, 10.1080/13880200600591758.
30. Kumar, V., Potential medicinal plants for CNS disorders: an overview. Phyther. Res. 20 (2006), 1023–1035, 10.1002/ptr.1970.
31. Lau, A., Tymianski, M., Glutamate receptors, neurotoxicity and neurodegeneration. Pflügers Arch. J. Physiol. 460 (2010), 525–542, 10.1007/s00424-010-0809-1.
32. Liu, W., Lang, M., Youdim, M.B.H., Amit, T., Sun, Y., Zhang, Z., Wang, Y., Weinreb, O., Design, synthesis and evaluation of novel dual monoamine-cholinesterase inhibitors as potential treatment for Alzheimer's disease. Neuropharmacology 109 (2016), 376–385, 10.1016/j.neuropharm.2016.06.013.
33. Macdonald, I.R., Rockwood, K., Martin, E., Darvesh, S., Cholinesterase inhibition in Alzheimer's disease: is specificity the answer?. J. Alzheimer's Dis. 42 (2014), 379–384, 10.3233/JAD-140219.
34. Nabavi, S.F., Braidy, N., Gortzi, O., Sobarzo-Sanchez, E., Daglia, M., Skalicka-Wooniak, K., Nabavi, S.M., Luteolin as an anti-inflammatory and neuroprotective agent: a brief review. Brain Res. Bull. 119 (2015), 1–11, 10.1016/j.brainresbull.2015.09.002.
35. Novaroli, L., Reist, M., Favre, E., Carotti, A., Catto, M., Carrupt, P.A., Human recombinant monoamine oxidase B as reliable and efficient enzyme source for inhibitor screening. Bioorg. Med. Chem. 13 (2005), 6212–6217, 10.1016/j.bmc.2005.06.043.
36. Piacente, S., Camargo, E.E.S., Zampelli, A., Gracioso, J.S., Souza Brito, A.R., Pizza, C., Vilegas, W., Flavonoids and arbutin from Turnera diffusa. Z. fur Naturforsch. - Sect. C J. Biosci. 57 (2002), 983–985, 10.1515/znc-2002-11-1204.
37. Rajput, S.B., Tonge, M.B., Karuppayil, S.M., An overview on traditional uses and pharmacological profile of Acorus calamus Linn. (Sweet flag) and other Acorus species. Phytomedicine 21 (2014), 268–276, 10.1016/j.phymed.2013.09.020.
38. Sheldon, A.L., Robinson, M.B., The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem. Int. 51 (2007), 333–355, 10.1016/j.neuint.2007.03.012.
39. Shukla, V., Mishra, S.K., Pant, H.C., Oxidative stress in neurodegeneration. Adv. Pharmacol. Sci., 2011, 2011, 572634, 10.1155/2011/572634.
40. Sierksma, A.S.R., van den Hove, D.L.A., Steinbusch, H.W.M., Prickaerts, J., Major depression, cognitive dysfunction and Alzheimer's disease: is there a link?. Eur. J. Pharmacol. 1 (2010), 72–82, 10.1016/j.ejphar.2009.10.021.
41. Solanki, I., Parihar, P., Mansuri, M.L., Parihar, M.S., Flavonoid-based therapies in the early management of neurodegenerative diseases. Adv. Nutr. 6 (2015), 64–72, 10.3945/an.114.007500.
42. Sousa, C., Andrade, P.B., Valentão, P., Relationships of Echium plantagineum L. bee pollen, dietary flavonoids and their colonic metabolites with cytochrome P450 enzymes and oxidative stress. RSC Adv. 6 (2016), 6084–6092, 10.1039/C5RA26736F.
43. Sun, Z.-W., Zhang, L., Zhu, S.-J., Chen, W.-C., Mei, B., Excitotoxicity effects of glutamate on human neuroblastoma SH-SY5Y cells via oxidative damage. Neurosci. Bull. 26 (2010), 8–16, 10.1007/s12264-010-0813-7.
44. Szewczyk, K., Zidorn, C., Ethnobotany, phytochemistry, and bioactivity of the genus Turnera (Passifloraceae) with a focus on damiana - Turnera diffusa. J. Ethnopharmacol. 152 (2014), 424–443, 10.1016/j.jep.2014.01.019.
45. Taveira, M., Sousa, C., Valentão, P., Ferreres, F., Teixeira, J.P., Andrade, P.B., Neuroprotective effect of steroidal alkaloids on glutamate-induced toxicity by preserving mitochondrial membrane potential and reducing oxidative stress. J. Steroid Biochem. Mol. Biol. 140 (2014), 106–115, 10.1016/j.jsbmb.2013.12.013.
46. Vauzour, D., Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial effects. Oxid. Med. Cell. Longev., 2012, 2012, 914273, 10.1155/2012/914273.
47. Wszelaki, N., Kuciun, A., Kiss, A., Screening of traditional European herbal medicines for acetylcholinesterase and butyrylcholinesterase inhibitory activity. Acta Pharm. 60 (2010), 119–128, 10.2478/v10007-010-0006-y.
48. Youdim, M.B.H., Buccafusco, J.J., Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders. Trends Pharmacol. Sci. 1 (2005), 27–35, 10.1016/j.tips.2004.11.007.
49. Zhao, G., Yao-Yue, C., Qin, G.W., Guo, L.H., Luteolin from Purple perilla mitigates ROS insult particularly in primary neurons. Neurobiol. Aging 33 (2012), 176–186, 10.1016/j.neurobiolaging.2010.02.013.
50. Zhao, J., Pawar, R.S., Ali, Z., Khan, I.A., Phytochemical investigation of Turnera diffusa. J. Nat. Prod. 70 (2007), 289–292, 10.1021/np060253r.
51. Zhao, K., Luo, G., Giannelli, S., Szeto, H.H., Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines. Biochem. Pharmacol. 70 (2005), 1796–1806, 10.1016/j.bcp.2005.08.022.